Antibodies

The Drug Discovery Initiative has developed relationships with several antibody development companies using humanized mouse and phage display platforms. UNC researchers can work with these companies under a fee-for-service arrangement or potentially through no-cost access in exchange for shared IP.

To submit targets for consideration and assessment, please use the AdvanTx Portal.